Hydrogen sulfide and the liver

Nitric Oxide - Biology and Chemistry

Volumn 41, Issue , 2014, Pages 62-71

  Mani, Sarathi ^a   Cao, Wei ^a,b,c   Wu, Lingyun ^a,b   Wang, Rui ^a  

^a LAKEHEAD UNIVERSITY   (Canada)

^b Thunder Bay Regional Research Institute   (Canada)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cirrhosis; Diabetes; Hydrogen sulfide; Lipids; Liver; Oxidative stress

Indexed keywords

CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; GLUCOSE; HYDROGEN SULFIDE; LIPID; SULFURTRANSFERASE;

BIOENERGY; BIOGENESIS; ENZYME MECHANISM; ENZYME SYNTHESIS; GLUCOSE METABOLISM; HUMAN; INSULIN SENSITIVITY; LIPID LIVER LEVEL; LIPID METABOLISM; LIPOPROTEIN METABOLISM; LIPOPROTEIN SYNTHESIS; LIVER; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION; LIVER PROTECTION; LIVER TOXICITY; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; REVIEW; ANIMAL; CHEMISTRY; DIABETES MELLITUS; LIVER DISEASE; METABOLISM; MOUSE; PHYSIOLOGY; RAT;

ANIMALS; DIABETES MELLITUS; GLUCOSE; HUMANS; HYDROGEN SULFIDE; LIPID METABOLISM; LIVER; LIVER DISEASES; MICE; RATS;

EID: 84907597267     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2014.02.006     Document Type: Review

References (129)

1. R. Wang, Physiological implications of hydrogen sulfide: A whiff exploration that blossomed, Physiol. Rev. 92 (2012) 791-896.
2. D.G. Searcy, S.H. Lee, Sulfur reduction by human erythrocytes, J. Exp. Zool. 282 (1998) 310-322.
3. R. Wang, Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?, FASEB J 16 (2002) 1792-1798.
4. J. Furne, A. Saeed, M.D. Levitt, Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values, Am. J. Physiol. Regul. Integr. Comp. Physiol. 295 (2008). R1479-85.
5. D.J. Lefer, A new gaseous signaling molecule emerges: cardioprotective role of hydrogen sulfide, Proc. Natl. Acad. Sci. USA 104 (2007) 17907-17908.
6. H. Teng, B. Wu, K. Zhao, G. Yang, L. Wu, R. Wang, Oxygen-sensitive mitochondrial accumulation of cystathionine beta-synthase mediated by Lon protease, Proc. Natl. Acad. Sci. USA 110 (2013) 12679-12684.
7. C. Szabo, Hydrogen sulphide and its therapeutic potential, Nat. Rev. Drug Discov. 6 (2007) 917-935.
8. M. Whiteman, S. Le Trionnaire, M. Chopra, B. Fox, J. Whatmore, Emerging role of hydrogen sulfide in health and disease: critical appraisal of biomarkers and pharmacological tools, Clin. Sci. (Lond) 121 (2011) 459-488.
9. G. Yang, L. Wu, B. Jiang, W. Yang, J. Qi, K. Cao, Q. Meng, A.K. Mustafa, W. Mu, S. Zhang, S.H. Snyder, R. Wang, H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase, Science 322 (2008) 587- 590.
10. S. Mani, H. Li, A. Untereiner, L. Wu, G. Yang, R.C. Austin, J.G. Dickhout, S. Lhotak, Q.H. Meng, R. Wang, Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis, Circulation 127 (2013) 2523-2534.
11. S. Mani, A. Untereiner, L. Wu, R. Wang, Hydrogen Sulfide and the Pathogenesis of Atherosclerosis, Antioxid. Redox Signal. (2013).
12. A.A. Untereiner, A. Dhar, J. Liu, L. Wu, Increased renal methylglyoxal formation with down-regulation of PGC-1alpha-FBPase pathway in cystathionine gamma-lyase knockout mice, PLoS ONE 6 (2011) e29592.
13. I. Ishii, N. Akahoshi, X.N. Yu, Y. Kobayashi, K. Namekata, G. Komaki, H. Kimura, Murine cystathionine gamma-lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression, Biochem. J. 381 (2004) 113-123.
14. P. Tripatara, N.S. Patel, V. Brancaleone, D. Renshaw, J. Rocha, B. Sepodes, H. Mota-Filipe, M. Perretti, C. Thiemermann, Characterisation of cystathionine gamma-lyase/hydrogen sulphide pathway in ischaemia/reperfusion injury of the mouse kidney: An in vivo study, Eur. J. Pharmacol. 606 (2009) 205-209.
15. L. Wu, W. Yang, X. Jia, G. Yang, D. Duridanova, K. Cao, R. Wang, Pancreatic islet overproduction of H2S and suppressed insulin release in Zucker diabetic rats, Lab. Invest. 89 (2009) 59-67.
16. T. Chang, A. Untereiner, J. Liu, L. Wu, Interaction of methylglyoxal and hydrogen sulfide in rat vascular smooth muscle cells, Antioxid. Redox Signal. 12 (2010) 1093-1100.
17. W. Zhao, J. Zhang, Y. Lu, R. Wang, The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener, EMBO J. 20 (2001) 6008-6016.
18. G. Yang, X. Sun, R. Wang, Hydrogen sulfide-induced apoptosis of human aorta smooth muscle cells via the activation of mitogen-activated protein kinases and caspase-3, FASEB J. 18 (2004) 1782-1784.
19. Y.H. Chen, W.Z. Yao, Y.L. Ding, B. Geng, M. Lu, C.S. Tang, Effect of theophylline on endogenous hydrogen sulfide production in patients with COPD, Pulm. Pharmacol. Ther. 21 (2008) 40-46.
20. P. Wang, G. Zhang, T. Wondimu, B. Ross, R. Wang, Hydrogen sulfide and asthma, Exp. Physiol. 96 (2011) 847-852.
21. P.F. Erickson, I.H. Maxwell, L.J. Su, M. Baumann, L.M. Glode, Sequence of cDNA for rat cystathionine gamma-lyase and comparison of deduced amino acid sequence with related Escherichia coli enzymes, Biochem. J. 269 (1990) 335- 340.
22. K. Abe, H. Kimura, The possible role of hydrogen sulfide as an endogenous neuromodulator, J. Neurosci. 16 (1996) 1066-1071.
23. M.H. Stipanuk, P.W. Beck, Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat, Biochem. J. 206 (1982) 267-277.
24. K. Robert, J.F. Chasse, D. Santiard-Baron, C. Vayssettes, A. Chabli, J. Aupetit, N. Maeda, P. Kamoun, J. London, N. Janel, Altered gene expression in liver from a murine model of hyperhomocysteinemia, J. Biol. Chem. 278 (2003) 31504- 31511.
25. M.D. Levitt, J. Furne, J. Springfield, F. Suarez, E. DeMaster, Detoxification of hydrogen sulfide and methanethiol in the cecal mucosa, J. Clin. Invest. 104 (1999) 1107-1114.
26. A.M. Morselli-Labate, L. Fantini, R. Pezzilli, Hydrogen sulfide, nitric oxide and a molecular mass 66 u substance in the exhaled breath of chronic pancreatitis patients, Pancreatology 7 (2007) 497-504.
27. F. Suarez, J. Springfield, J. Furne, M. Levitt, Differentiation of mouth versus gut as site of origin of odoriferous breath gases after garlic ingestion, Am. J. Physiol. 276 (1999). G425-30.
28. P. Nguyen, V. Leray, M. Diez, S. Serisier, J. Le Bloc'h, B. Siliart, H. Dumon, Liver lipid metabolism, J. Anim. Physiol. Anim. Nutr. (Berl) 92 (2008) 272-283.
29. M.K. Hellerstein, J.M. Schwarz, R.A. Neese, Regulation of hepatic de novo lipogenesis in humans, Annu. Rev. Nutr. 16 (1996) 523-557.
30. M. Sundaram, Z. Yao, Intrahepatic role of exchangeable apolipoproteins in lipoprotein assembly and secretion, Arterioscler. Thromb. Vasc. Biol. 32 (2012) 1073-1078.
31. D.B. Savage, R.K. Semple, Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance, Curr. Opin. Lipidol. 21 (2010) 329-336.
32. K.L. Donnelly, C.I. Smith, S.J. Schwarzenberg, J. Jessurun, M.D. Boldt, E.J. Parks, Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease, J. Clin. Invest. 115 (2005) 1343-1351.
33. J.M. Lavoie, M.S. Gauthier, Regulation of fat metabolism in the liver: link to non-alcoholic hepatic steatosis and impact of physical exercise, Cell. Mol. Life Sci. 63 (2006) 1393-1409.
34. P. Angulo, Obesity and nonalcoholic fatty liver disease, Nutr. Rev. 65 (2007) S57-S63.
35. P. Loria, A. Lonardo, S. Bellentani, C.P. Day, G. Marchesini, N. Carulli, Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question, Nutr. Metab. Cardiovasc. Dis. 17 (2007) 684-698.
36. M. Watanabe, J. Osada, Y. Aratani, K. Kluckman, R. Reddick, M.R. Malinow, N. Maeda, Mice deficient in cystathionine beta-synthase: Animal models for mild and severe homocyst(e)inemia, Proc. Natl. Acad. Sci. USA 92 (1995) 1585-1589.
37. K. Robert, J. Nehme, E. Bourdon, G. Pivert, B. Friguet, C. Delcayre, J.M. Delabar, N. Janel, Cystathionine beta synthase deficiency promotes oxidative stress, fibrosis, and steatosis in mice liver, Gastroenterology 128 (2005) 1405-1415.
38. J. Hamelet, K. Demuth, J.L. Paul, J.M. Delabar, N. Janel, Hyperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice, J. Hepatol. 46 (2007) 151-159.
39. S. Mani, G. Yang, R. Wang, A critical life-supporting role for cystathionine gamma-lyase in the absence of dietary cysteine supply, Free Radic. Biol. Med. 50 (2011) 1280-1287.
40. S.Y. Hwang, L.K. Sarna, Y.L. Siow, K. O, High-fat diet stimulates hepatic cystathionine beta-synthase and cystathionine gamma-lyase expression, Can. J. Physiol. Pharmacol. 91 (2013) 913-919.
41. E.J. Norris, C.R. Culberson, S. Narasimhan, M.G. Clemens, The liver as a central regulator of hydrogen sulfide, Shock 36 (2011) 242-250.
42. K. Namekata, Y. Enokido, I. Ishii, Y. Nagai, T. Harada, H. Kimura, Abnormal lipid metabolism in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia, J. Biol. Chem. 279 (2004) 52961-52969.
43. J. Zhou, G.H. Werstuck, S. Lhotak, Y.Y. Shi, V. Tedesco, B. Trigatti, J. Dickhout, A.K. Majors, P.M. DiBello, D.W. Jacobsen, R.C. Austin, Hyperhomocysteinemia induced by methionine supplementation does not independently cause atherosclerosis in C57BL/6J mice, FASEB J. 22 (2008) 2569-2578.
44. S.K. Jain, D. Micinski, B.J. Lieblong, T. Stapleton, Relationship between hydrogen sulfide levels and HDL-cholesterol, adiponectin, and potassium levels in the blood of healthy subjects, Atherosclerosis 225 (2012) 242-245.
45. G. Wojcicka, A. Jamroz-Wisniewska, P. Atanasova, G.N. Chaldakov, B. Chylinska-Kula, J. Beltowski, Differential effects of statins on endogenous H2S formation in perivascular adipose tissue, Pharmacol. Res. 63 (2011) 68-76.
46. M.S. Butt, M.T. Sultan, J. Iqbal, Garlic: nature's protection against physiological threats, Crit. Rev. Food Sci. Nutr. 49 (2009) 538-551.
47. G.A. Benavides, G.L. Squadrito, R.W. Mills, H.D. Patel, T.S. Isbell, R.P. Patel, V.M. Darley-Usmar, J.E. Doeller, D.W. Kraus, Hydrogen sulfide mediates the vasoactivity of garlic, Proc. Natl. Acad. Sci. USA 104 (2007) 17977-17982.
48. T. Zeng, C.L. Zhang, F.Y. Song, X.L. Zhao, K.Q. Xie, Garlic oil alleviated ethanolinduced fat accumulation via modulation of SREBP-1, PPAR-alpha, and CYP2E1, Food Chem. Toxicol. 50 (2012) 485-491.
49. R. Meshkani, K. Adeli, Hepatic insulin resistance, metabolic syndrome and cardiovascular disease, Clin. Biochem. 42 (2009) 1331-1346.
50. E. Bugianesi, A.J. McCullough, G. Marchesini, Insulin resistance. a metabolic pathway to chronic liver disease, Hepatology 42 (2005) 987-1000.
51. M. Yusuf, B.T. Kwong Huat, A. Hsu, M. Whiteman, M. Bhatia, P.K. Moore, Streptozotocin-induced diabetes in the rat is associated with enhanced tissue hydrogen sulfide biosynthesis, Biochem. Biophys. Res. Commun. 333 (2005) 1146-1152.
52. B. Wilinski, J. Wilinski, E. Somogyi, J. Piotrowska, W. Opoka, Metformin raises hydrogen sulfide tissue concentrations in various mouse organs, Pharmacol. Rep. 65 (2013) 737-742.
53. L. Zhang, G. Yang, A. Untereiner, Y. Ju, L. Wu, R. Wang, Hydrogen sulfide impairs glucose utilization and increases gluconeogenesis in hepatocytes, Endocrinology 154 (2013) 114-126.
54. C. Szabo, Roles of hydrogen sulfide in the pathogenesis of diabetes mellitus and its complications, Antioxid. Redox Signal. 17 (2012) 68-80.
55. L. Wu, J. de Champlain, Effects of superoxide on signaling pathways in smooth muscle cells from rats, Hypertension 34 (1999) 1247-1253.
56. L. Wu, J. de Champlain, Superoxide anion-induced formation of inositol phosphates involves tyrosine kinase activation in smooth muscle cells from rat mesenteric artery, Biochem. Biophys. Res. Commun. 259 (1999) 239-243.
57. J.D. Browning, J.D. Horton, Molecular mediators of hepatic steatosis and liver injury, J. Clin. Invest. 114 (2004) 147-152.
58. P. Tessari, A. Coracina, A. Cosma, A. Tiengo, Hepatic lipid metabolism and non-alcoholic fatty liver disease, Nutr. Metab. Cardiovasc. Dis. 19 (2009) 291- 302.
59. Y. Ju, W. Zhang, Y. Pei, G. Yang, H(2)S signaling in redox regulation of cellular functions, Can. J. Physiol. Pharmacol. 91 (2013) 8-14.
60. V. Jeney, E. Komodi, E. Nagy, A. Zarjou, G.M. Vercellotti, J.W. Eaton, G. Balla, J. Balla, Supression of hemin-mediated oxidation of low-density lipoprotein and subsequent endothelial reactions by hydrogen sulfide (H(2)S), Free Radic. Biol. Med. 46 (2009) 616-623.
61. H. Laggner, M.K. Muellner, S. Schreier, B. Sturm, M. Hermann, M. Exner, B.M. Gmeiner, S. Kapiotis, Hydrogen sulphide: A novel physiological inhibitor of LDL atherogenic modification by HOCl, Free Radic. Res. 41 (2007) 741-747.
62. H. Xue, P. Yuan, J. Ni, C. Li, D. Shao, J. Liu, Y. Shen, Z. Wang, L. Zhou, W. Zhang, Y. Huang, C. Yu, R. Wang, L. Lu, H2S inhibits hyperglycemia-Induced intrarenal renin-angiotensin system activation via attenuation of reactive oxygen species generation, PLoS ONE 8 (2013) e74366.
63. N.N. Osborne, D. Ji, A.S. Majid, P. Del Soldata, A. Sparatore, Glutamate oxidative injury to RGC-5 cells in culture is necrostatin sensitive and blunted by a hydrogen sulfide (H2S)-releasing derivative of aspirin (ACS14), Neurochem. Int. 60 (2012) 365-378.
64. J.L. Evans, B.A. Maddux, I.D. Goldfine, The molecular basis for oxidative stressinduced insulin resistance, Antioxid. Redox Signal. 7 (2005) 1040-1052.
65. S. Gawrieh, E.C. Opara, T.R. Koch, Oxidative stress in nonalcoholic fatty liver disease: pathogenesis and antioxidant therapies, J. Investig. Med. 52 (2004) 506-514.
66. G. Poli, Pathogenesis of liver fibrosis: role of oxidative stress, Mol. Aspects Med. 21 (2000) 49-98.
67. S. Jha, J.W. Calvert, M.R. Duranski, A. Ramachandran, D.J. Lefer, Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling, Am. J. Physiol. Heart Circ. Physiol. 295 (2008). H801-6.
68. G. Yang, Hydrogen sulfide in cell survival: A double-edged sword, Expert Rev. Clin. Pharmacol. 4 (2011) 33-47.
69. G. Tan, S. Pan, J. Li, X. Dong, K. Kang, M. Zhao, X. Jiang, J.R. Kanwar, H. Qiao, H. Jiang, X. Sun, Hydrogen sulfide attenuates carbon tetrachloride-induced hepatotoxicity, liver cirrhosis and portal hypertension in rats, PLoS ONE 6 (2011) e25943.
70. G. Yang, K. Zhao, Y. Ju, S. Mani, Q. Cao, S. Puukila, N. Khaper, L. Wu, R. Wang, Hydrogen sulfide protects against cellular senescence via S-sulfhydration of Keap1 and activation of Nrf2, Antioxid. Redox Signal. 18 (2013) 1906-1919.
71. J.M. Hourihan, J.G. Kenna, J.D. Hayes, The gasotransmitter hydrogen sulfide induces nrf2-target genes by inactivating the keap1 ubiquitin ligase substrate adaptor through formation of a disulfide bond between cys-226 and cys-613, Antioxid. Redox Signal. 19 (2013) 465-481.
72. I. Ishii, N. Akahoshi, H. Yamada, S. Nakano, T. Izumi, M. Suematsu, Cystathionine gamma-Lyase-deficient mice require dietary cysteine to protect against acute lethal myopathy and oxidative injury, J. Biol. Chem. 285 (2010) 26358-26368.
73. K. Modis, A. Asimakopoulou, C. Coletta, A. Papapetropoulos, C. Szabo, Oxidative stress suppresses the cellular bioenergetic effect of the 3- mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway, Biochem. Biophys. Res. Commun. 433 (2013) 401-407.
74. N. Zarkovic, 4-hydroxynonenal as a bioactive marker of pathophysiological processes, Mol. Aspects Med. 24 (2003) 281-291.
75. K.J. Davies, Protein damage and degradation by oxygen radicals. I. general aspects, J. Biol. Chem. 262 (1987) 9895-9901.
76. K. Houglum, M. Filip, J.L. Witztum, M. Chojkier, Malondialdehyde and 4- hydroxynonenal protein adducts in plasma and liver of rats with iron overload, J. Clin. Invest. 86 (1990) 1991-1998.
77. M.A. Morsy, S.A. Ibrahim, S.A. Abdelwahab, M.Z. Zedan, H.I. Elbitar, Curative effects of hydrogen sulfide against acetaminophen-induced hepatotoxicity in mice, Life Sci. 87 (2010) 692-698.
78. R. Padiya, T.N. Khatua, P.K. Bagul, M. Kuncha, S.K. Banerjee, Garlic improves insulin sensitivity and associated metabolic syndromes in fructose fed rats, Nutr. Metab. (Lond) 8 (2011) 53.
79. D.H. Truong, M.A. Eghbal, W. Hindmarsh, S.H. Roth, P.J. O'Brien, Molecular mechanisms of hydrogen sulfide toxicity, Drug Metab. Rev. 38 (2006) 733- 744.
80. C.G. Zou, S.Y. Gao, Y.S. Zhao, S.D. Li, X.Z. Cao, Y. Zhang, K.Q. Zhang, Homocysteine enhances cell proliferation in hepatic myofibroblastic stellate cells, J. Mol. Med. (Berl) 87 (2009) 75-84.
81. K. Shirozu, K. Tokuda, E. Marutani, D. Lefer, R. Wang, F. Ichinose, Cystathionine gamma-lyase deficiency protects mice from galactosamine/ lipopolysaccharideinduced acute liver failure, Antioxid. Redox Signal. (2013).
82. J.M. McMillan, Galactosamine decreases nitric oxide formation in cultured rat hepatocytes: lack of involvement in cytotoxicity, J. Biochem. Mol. Toxicol. 13 (1999) 135-142.
83. T. Taguchi, S. Awata, M. Nishioka, Y. Arakawa, N. Shiraishi, S. Ryu, H. Kumazawa, Y.T. Takano, K. Nakayama, K. Yagyu, et al., Elevation of cystathionine gamma-lyase activity in the serum of rats treated with a single dose of carbon tetrachloride, Ind. Health 33 (1995) 199-205.
84. M. Saraste, Oxidative phosphorylation at the fin de siecle, Science 283 (1999) 1488-1493.
85. J.F. Turrens, Mitochondrial formation of reactive oxygen species, J. Physiol. 552 (2003) 335-344.
86. M.J. Berridge, P. Lipp, M.D. Bootman, The versatility and universality of calcium signalling, Nat. Rev. Mol. Cell Biol. 1 (2000) 11-21.
87. J.D. Erusalimsky, S. Moncada, Nitric oxide and mitochondrial signaling: from physiology to pathophysiology, Arterioscler. Thromb. Vasc. Biol. 27 (2007) 2524-2531.
88. L.L. Yao, X.W. Huang, Y.G. Wang, Y.X. Cao, C.C. Zhang, Y.C. Zhu, Hydrogen sulfide protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by preventing GSK-3beta-dependent opening of mPTP, Am. J. Physiol. Heart Circ. Physiol. 298 (2010). H1310-9.
89. M. Fu, W. Zhang, L. Wu, G. Yang, H. Li, R. Wang, Hydrogen sulfide (H2S) metabolism in mitochondria and its regulatory role in energy production, Proc. Natl. Acad. Sci. USA 109 (2012) 2943-2948.
90. E. Blackstone, M. Morrison, M.B. Roth, H2S induces a suspended animationlike state in mice, Science 308 (2005) 518.
91. E. Lagoutte, S. Mimoun, M. Andriamihaja, C. Chaumontet, F. Blachier, F. Bouillaud, Oxidation of hydrogen sulfide remains a priority in mammalian cells and causes reverse electron transfer in colonocytes, Biochim. Biophys. Acta 1797 (2010) 1500-1511.
92. D.G. Searcy, Metabolic integration during the evolutionary origin of mitochondria, Cell Res. 13 (2003) 229-238.
93. R.H. Bhogal, S.M. Curbishley, C.J. Weston, D.H. Adams, S.C. Afford, Reactive oxygen species mediate human hepatocyte injury during hypoxia/reoxygenation, Liver Transplant. 16 (2010) 1303-1313.
94. K.P. Mollen, C.A. McCloskey, H. Tanaka, J.M. Prince, R.M. Levy, B.S. Zuckerbraun, T.R. Billiar, Hypoxia activates c-Jun N-terminal kinase via Rac1-dependent reactive oxygen species production in hepatocytes, Shock 28 (2007) 270-277.
95. K. Modis, C. Coletta, K. Erdelyi, A. Papapetropoulos, C. Szabo, Intramitochondrial hydrogen sulfide production by 3-mercaptopyruvate sulfurtransferase maintains mitochondrial electron flow and supports cellular bioenergetics, FASEB J. 27 (2013) 601-611.
96. C.W. Shepard, L. Finelli, M.J. Alter, Global epidemiology of hepatitis C virus infection, Lancet Infect. Dis. 5 (2005) 558-567.
97. D.A. Leon, L. Saburova, S. Tomkins, E. Andreev, N. Kiryanov, M. McKee, V.M. Shkolnikov, Hazardous alcohol drinking and premature mortality in Russia: A population based case-control study, Lancet 369 (2007) 2001-2009.
98. G.C. Farrell, C.Z. Larter, Nonalcoholic fatty liver disease: from steatosis to cirrhosis, Hepatology 43 (2006) S99-S112.
99. S.L. Friedman, Liver fibrosis - from bench to bedside, J. Hepatol. 38 (Suppl 1) (2003) S38-S53.
100. C. Bosetti, F. Levi, F. Lucchini, W.A. Zatonski, E. Negri, C. La Vecchia, Worldwide mortality from cirrhosis: An update to 2002, J. Hepatol. 46 (2007) 827-839.
101. S. Fiorucci, E. Antonelli, A. Mencarelli, S. Orlandi, B. Renga, G. Rizzo, E. Distrutti, V. Shah, A. Morelli, The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis, Hepatology 42 (2005) 539-548.
102. X. Gu, Y.Z. Zhu, Therapeutic applications of organosulfur compounds as novel hydrogen sulfide donors and/or mediators, Expert Rev. Clin. Pharmacol. 4 (2011) 123-133.
103. G. Targher, G. Arcaro, Non-alcoholic fatty liver disease and increased risk of cardiovascular disease, Atherosclerosis 191 (2007) 235-240.
104. R.H. Eckel, S.M. Grundy, P.Z. Zimmet, The metabolic syndrome, Lancet 365 (2005) 1415-1428.
105. Z. Kmiec, Cooperation of liver cells in health and disease, Adv. Anat. Embryol. Cell Biol. 161 (2001). III-XIII, 1-151.
106. Q. Shen, Z. Qin, A. Lu, Preventive effect of exogenous hydrogen sulfide on hepatic fibrosis in rats, Zhong Nan Da Xue Xue Bao Yi Xue Ban 37 (2012) 911- 915.
107. H.N. Fan, H.J. Wang, L. Ren, B. Ren, C.R. Dan, Y.F. Li, L.Z. Hou, Y. Deng, Decreased expression of p38 MAPK mediates protective effects of hydrogen sulfide on hepatic fibrosis, Eur. Rev.Med. Pharmacol. Sci. 17 (2013) 644-652.
108. R. Moreau, H. Komeichi, S. Cailmail, D. Lebrec, Blockade of ATP-sensitive K+ channels by glibenclamide reduces portal pressure and hyperkinetic circulation in portal hypertensive rats, J. Hepatol. 16 (1992) 215-218.
109. K.G. Brown, J.A. Strickland, Utilizing data from multiple studies (metaanalysis) to determine effective dose-duration levels. Example: rats and mice exposed to hydrogen sulfide, Regul. Toxicol. Pharmacol. 37 (2003) 305-317.
110. R.S. Koti, A.M. Seifalian, B.R. Davidson, Protection of the liver by ischemic preconditioning: A review of mechanisms and clinical applications, Dig. Surg. 20 (2003) 383-396.
111. K. Kang, M. Zhao, H. Jiang, G. Tan, S. Pan, X. Sun, Role of hydrogen sulfide in hepatic ischemia-reperfusion-induced injury in rats, Liver Transplant. 15 (2009) 1306-1314.
112. R.J. Reiffenstein, W.C. Hulbert, S.H. Roth, Toxicology of hydrogen sulfide, Annu. Rev. Pharmacol. Toxicol. 32 (1992) 109-134.
113. C. Yalamanchili, M.D. Smith, Acute hydrogen sulfide toxicity due to sewer gas exposure, Am. J. Emerg. Med. 26 (518) (2008) e5-e7.
114. R.O. Beauchamp Jr., J.S. Bus, J.A. Popp, C.J. Boreiko, D.A. Andjelkovich, A critical review of the literature on hydrogen sulfide toxicity, Crit. Rev. Toxicol. 13 (1984) 25-97.
115. T.W. Mitchell, J.C. Savage, D.H. Gould, High-performance liquid chromatography detection of sulfide in tissues from sulfide-treated mice, J. Appl. Toxicol. 13 (1993) 389-394.
116. L. Li, M. Bhatia, Y.Z. Zhu, Y.C. Zhu, R.D. Ramnath, Z.J. Wang, F.B. Anuar, M. Whiteman, M. Salto-Tellez, P.K. Moore, Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse, FASEB J. 19 (2005) 1196-1198.
117. E.J. Norris, N. Feilen, N.H. Nguyen, C.R. Culberson, M.C. Shin, M. Fish, M.G. Clemens, Hydrogen sulfide modulates sinusoidal constriction and contributes to hepatic microcirculatory dysfunction during endotoxemia, Am. J. Physiol. Gastrointest Liver Physiol. 304 (2013). G1070-8.
118. R. Baveja, N. Kresge, J.H. Ashburn, S. Keller, Y. Yokoyama, N. Sonin, J.X. Zhang, T. Huynh, M.G. Clemens, Potentiated hepatic microcirculatory response to endothelin-1 during polymicrobial sepsis, Shock 18 (2002) 415-422.
119. W.S. Kamoun, M.C. Shin, A. Karaa, M.G. Clemens, Quantification of hepatic microcirculation heterogeneity of perfusion: effects of endothelin-1, Microvasc. Res. 69 (2005) 180-186.
120. G. Tang, L. Wu, W. Liang, R. Wang, Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells, Mol. Pharmacol. 68 (2005) 1757-1764.
121. D.C. Dorman, F.J. Moulin, B.E. McManus, K.C. Mahle, R.A. James, M.F. Struve, Cytochrome oxidase inhibition induced by acute hydrogen sulfide inhalation: correlation with tissue sulfide concentrations in the rat brain, liver, lung, and nasal epithelium, Toxicol. Sci. 65 (2002) 18-25.
122. T.L. Guidotti, Hydrogen sulfide: Advances in understanding human toxicity, Int. J. Toxicol. 29 (2010) 569-581.
123. B.C. Hill, T.C. Woon, P. Nicholls, J. Peterson, C. Greenwood, A.J. Thomson, Interactions of sulphide and other ligands with cytochrome c oxidase. An electron-paramagnetic-resonance study, Biochem. J. 224 (1984) 591-600.
124. V. Tiranti, M. Zeviani, Altered sulfide (H(2)S) metabolism in ethylmalonic encephalopathy, Cold Spring Harb. Perspect. Biol. 5 (2013) a011437.
125. I. Di Meo, G. Fagiolari, A. Prelle, C. Viscomi, M. Zeviani, V. Tiranti, Chronic exposure to sulfide causes accelerated degradation of cytochrome c oxidase in ethylmalonic encephalopathy, Antioxid. Redox Signal. 15 (2011) 353-362.
126. M.A. Eghbal, P.S. Pennefather, P.J. O'Brien, H2S cytotoxicity mechanism involves reactive oxygen species formation and mitochondrial depolarisation, Toxicology 203 (2004) 69-76.
127. X. Wang, X. Chen, M. Chen, G. Hu, J. Ma, J. Pan, L. Hu, G. Lin, Assessment of effects of chronic hydrogen sulfide poisoning on cytochrome P450 isoforms activity of rats by cocktail approach, Biol. Pharm. Bull. 36 (2013) 1627-1633.
128. Y. Lu, A.I. Cederbaum, Cisplatin-induced hepatotoxicity is enhanced by elevated expression of cytochrome P450 2E1, Toxicol. Sci. 89 (2006) 515- 523.
129. C.Q. Chen, H. Xin, Y.Z. Zhu, Hydrogen sulfide: Third gaseous transmitter, but with great pharmacological potential, Acta Pharmacol. Sin. 28 (2007) 1709- 1716.